NUOPTY Trademark

Trademark Overview


On Wednesday, February 26, 2020, a trademark application was filed for NUOPTY with the United States Patent and Trademark Office. The USPTO has given the NUOPTY trademark a serial number of 79290702. The federal status of this trademark filing is REGISTERED as of Tuesday, January 26, 2021. This trademark is owned by H. Lundbeck A/S. The NUOPTY trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndr...
nuopty

General Information


Serial Number79290702
Word MarkNUOPTY
Filing DateWednesday, February 26, 2020
Status700 - REGISTERED
Status DateTuesday, January 26, 2021
Registration Number6253844
Registration DateTuesday, January 26, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2020

Trademark Statements


Goods and ServicesVaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, PSP, restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, headaches, pain, alcoholism and dependency, Diagnostic agents, reagents, preparations and substances for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 7, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameH. Lundbeck A/S
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDK

Party NameH. Lundbeck A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDK

Party NameH. Lundbeck A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDK

Trademark Events


Event DateEvent Description
Friday, March 22, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 22, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 22, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 22, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 22, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 17, 2022CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Saturday, February 19, 2022CORRECTION TRANSACTION RECEIVED FROM IB
Sunday, May 23, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, May 1, 2021FINAL DISPOSITION NOTICE SENT TO IB
Saturday, May 1, 2021FINAL DISPOSITION PROCESSED
Monday, April 26, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 26, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, November 10, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 21, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 8, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 7, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 7, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 7, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 27, 2020REFUSAL PROCESSED BY IB
Monday, September 7, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, September 5, 2020REFUSAL PROCESSED BY MPU
Tuesday, August 11, 2020APPLICATION FILING RECEIPT MAILED
Sunday, August 9, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, August 8, 2020NON-FINAL ACTION WRITTEN
Friday, August 7, 2020ASSIGNED TO EXAMINER
Friday, August 7, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 6, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 30, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB